Instrument Inactif

Communiqués Medlab Clinical Limited OTC Markets

Actions

13/01/23	Morgans rates MDC as Speculative Buy	AQ
12/01/23	MEDLAB ANNOUNCES FAVOURABLE INTERIM READOUT OF NANABIS™ REAL-WORLD EVIDENCE (RWE) MEDCARE STUDY	AQ
30/06/22	Medlab Clinical : Consolidation/Split - MDC	PU
13/04/22	Medlab Clinical : Quarterly Activities/Appendix 4C Cash Flow Report	PU
25/02/22	Morgans rates MDC as Add	AQ
14/01/22	Medlab (ASX:MDC) receives Government grant to apply NanoCelle® to an RNA nasal vaccine in collaboration with University of NSW (UNSW) and Macquarie University (MQ) to fight COVID-19 future potential epidemics	GL
16/11/21	Medlab Clinical : Presenting at Jefferies London Healthcare Conference	PU
04/11/21	Nanocelle® Patent Granted in Usa	AQ
11/10/21	Medlab Clinical : DEPRESSION PATENT FOR OROTATE APPROVED & GRANTED BY US PATENT OFFICE	AQ
06/10/21	Medlab Clinical : NANOCELLE “ISSUE OF ALLOWANCE” BY US PATENT OFFICE	AQ
27/07/21	US Patent Office issues Notice of Allowance status for NRGBiotic™ for treating, preventing, or Ameliorating depression or a Depressive disorder.	GL
23/07/21	Medlab Clinical Ltd (ASX:MDC) Executes Master Services Agreement with WEP Clinical Ltd	AQ
22/08/16	Medlab Clinical : and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial	MW